Khalid Al Rasadi

Muscat, MA, Oman

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Overview of pediatric and adult lysosomal acid lipase deficiency: expert recommendations from a Gulf cooperation council working group.

Overview of pediatric and adult lysosomal acid lipase deficiency: expert recommendations from a Gulf cooperation council working group.

Journal: Orphanet journal of rare diseases

Published: April 10, 2025

Rate of Screening for Obstructive Sleep Apnea Syndrome in Patients with Apparent Resistant Hypertension Attending a Tertiary Care Hospital.

Rate of Screening for Obstructive Sleep Apnea Syndrome in Patients with Apparent Resistant Hypertension Attending a Tertiary Care Hospital.

Journal: Oman medical journal

Published: November 18, 2024

Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.

Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.

Journal: Frontiers in nutrition

Published: December 14, 2023

The Frequency of Neuropsychiatric Sequelae After Traumatic Brain Injury in the Global South: A systematic review and meta-analysis.

The Frequency of Neuropsychiatric Sequelae After Traumatic Brain Injury in the Global South: A systematic review and meta-analysis.

Journal: Sultan Qaboos University medical journal

Published: April 16, 2023

The Frequency of Neuropsychiatric Sequelae After Traumatic Brain Injury in the Global South: A systematic review and meta-analysis.

The Frequency of Neuropsychiatric Sequelae After Traumatic Brain Injury in the Global South: A systematic review and meta-analysis.

Journal: Sultan Qaboos University medical journal

Published: April 16, 2023

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies.

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies.

Journal: Metabolites

Published: December 26, 2021

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes.

Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes.

Journal: Medicina (Kaunas, Lithuania)

Published: December 13, 2021

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Journal: Current atherosclerosis reports

Published: July 06, 2021

Antihypertensive Drugs and Perinatal Outcomes in Hypertensive Women Attending a Specialized Tertiary Hospital.

Antihypertensive Drugs and Perinatal Outcomes in Hypertensive Women Attending a Specialized Tertiary Hospital.

Journal: Oman medical journal

Published: April 21, 2021

Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease.

Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease.

Journal: JACC. Cardiovascular imaging

Published: October 04, 2019

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis.

Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis.

Journal: Archives of medical science : AMS

Published: June 15, 2019

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Journal: Cardiovascular diabetology

Published: April 24, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026